AstraZeneca Receives Six Months Pediatric Exclusivity for Casod...

AstraZeneca today announced that the United States Food and Drug Administration has granted an additional six-month period of exclusivity to market CASODEX for its licensed advanced prostate cancer indication ...

[daz]

What a crock of ShT . This means they have an extra 6 months before the drug can become generically available because they can test the safety and efficacy for pediatric use. How many pediatric patient's have prostate cancer?. The FDA has to be the most inept government agency.

[mad mom]

daz wrote:

What a crock of ShT . This means they have an extra 6 months before the drug can become generically available because they can test the safety and efficacy for pediatric use. How many pediatric patient's have prostate cancer?. The FDA h as to be the most inept government agency.

Sorry but two in chattanooga tn. alone,last year and my son who has already had a rare but unrelated cancer in 2007 just had tests for pediatric prostate,and these are not at ST. JUDE but at Children's Hospital in Chattanooga ! So sorry,my Dad also has adult prostate cancer.